Clinical trial
LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo…
NCT00159159 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00159159 |
|---|---|
| Title | LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant |
| Official title | LOW CYCLO: A Multicenter, Prospective, Randomized Study Evaluating the Benefit, on Renal Function, of Two Doses of Ciclosporine: Low Dose Versus Usual Dose, in Association With Mycophenolate and Corticoïds, in de Novo Cardiac Transplant |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiac Transplantion |
| Intervention type | Drug |
| Interventions | Ciclosporine 130 µg/l < T0 ciclosporinemia < 200 µg/l, Ciclosporine 200 µg/l < T0 ciclosporinemia < 300 µg/l |
| Enrollment | 106 |
| Start date | Mar 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 27, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: